| abstract |
The present invention relates to c-Met kinase inhibitor 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]tri Dihydrochloride and dibenzenesulfonate of azin-2-yl]benzamide, and pharmaceutical compositions thereof useful in the treatment of cancer and other diseases associated with disorders of the kinase pathway. The present invention also relates to the preparation of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl) imidazo[1,2-b][1,2,4]triazine- Processes and intermediates for 2-yl]benzamides and salts thereof. |